Review Article
Weight Gain, Obesity, and Psychotropic Prescribing
Table 1
Weight gain treatment options.
| Mode or medication | Weight loss produced | Duration of treatment |
| Behaviour modification | 0.5–0.7 kg per week | — | Cognitive-behavioral therapy | 4.5 drop in BMI | — | Naltreoxone and buropion | 4% | — | Phentermine and topiramate | 9% | 1 year | Sibutramine | 10–15% | <1 year | Orlistat | 10.2%, 8.8% | 1 year | Orlistat | >10% | 2 years | Orlistat | 34.6% | ? | Amantadine | 3.5 kg | 3–6 months | Nizatidine | Gained 3 kg less than patients who did not take Nizatidine | 16 weeks | Naltexone | 5 kg | 8 weeks | Topiramate augmentation | 10–15 lbs | — | Metformin | 15/19 patients lost weight | 12 weeks |
|
|